MyAverix Finance
US · Healthcare
Royalty Pharma Plc (RPRX)
Biotechnology
Royalty Pharma Plc (RPRX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for RPRX
Royalty Pharma Plc (RPRX) — FAQ
What is RPRX's P/E ratio?
The price-to-earnings (P/E) ratio for Royalty Pharma Plc (RPRX) is 18.00 (data as of 2026-03-23).
Does Royalty Pharma Plc pay a dividend?
Dividend yield is not available in the current snapshot for Royalty Pharma Plc (RPRX). Check the MyAverix Finance app for the latest dividend data.
What sector is Royalty Pharma Plc in?
Royalty Pharma Plc (RPRX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is RPRX listed on?
RPRX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.